Nachrichten zur Regeneron Pharmaceuticals Inc. Aktie

Regeneron (REGN) Gains But Lags Market: What You Should Know

Regeneron (REGN) closed the most recent trading day at $729.91, moving +1.1% from the previous trading session....…

Regeneron Pharmaceuticals: Hochstufung

New York (www.aktiencheck.de) - Rating-Update: Chris Schott, Analyst von J.P. Morgan Securities, stuft die Aktie von Regeneron Pharmaceuticals (ISIN: US75886F1075, WKN:…

Regeneron upgraded at JPMorgan on upcoming catalysts

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Annexin appoints Dr. Alain Thibault as Therapeutic Area Head of Oncology.

STOCKHOLM January 18, 2023 Annexin Pharmaceuticals AB (publ) announces that Dr. Thibault, a medical oncologist with extensive global experience leading…

Regeneron (REGN) Outpaces Stock Market Gains: What You Should Know

Regeneron (REGN) closed the most recent trading day at $714.57, moving +0.65% from the previous trading session....…

Biotech Stock Roundup: REGN Down on Eylea Data, CINC Surges on AZN Offer & More

Updates from Regeneron (REGN) and CinCor Pharma (CINC) are the key highlights from the biotech sector during the past week....…

Insiderhandel: Aufsichtsrat verkauft Aktien von Regeneron Pharmaceuticals im Wert von 2.293.720$

Brown, Michael S. - Aufsichtsrat - Tag der Transaktion: 2023-01-06...…

Regeneron Pharmaceuticals: Kaufempfehlung bestätigt

Minneapolis (www.aktiencheck.de) - Rating-Update: Christopher Raymond, Analyst von Piper Sandler, stuft die Aktie von Regeneron Pharmaceuticals (ISIN: US75886F1075, WKN: 881535, Ticker-Symbol:…

Regeneron slips after $0.21 per share impact to Q4 2022 earnings

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Regeneron Stock Sinks on Disappointing Sales of Eylea Vaccine

Eylea, which is injected into the eye, is meant to treat conditions such as macular degeneration, macular edema, and diabetic retinopathy....…

2seventy Bio, Regeneron in Amended Collaboration >TSVT REGN

2seventy Bio, Regeneron in Amended Collaboration >TSVT REGN...…

Insiderhandel: EVP Commercial verkauft Aktien von Regeneron Pharmaceuticals im Wert von 794.046$

Mccourt, Marion - Vorstand - Tag der Transaktion: 2023-01-03...…

Sensei Biotherapeutics Enters Clinical Supply Agreement With Regeneron For Libtayo

WASHINGTON (dpa-AFX) - Sensei Biotherapeutics, Inc. (SNSE) announced a clinical supply agreement with Regeneron for its anti-PD1 therapy Libtayo. The…

Sensei Biotherapeutics Announces Clinical Supply Agreement with Regeneron for Phase 1/2 Clinical Trial Evaluating SNS-101, a Conditionally Active VISTA-blocking Antibody, in Combination with Libtayo® (cemiplimab) in Solid Tumors

BOSTON, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), an immuno-oncology company focused on the…

Regeneron to Report Fourth Quarter and Full Year 2022 Financial and Operating Results and Host Conference Call and Webcast on February 3, 2023

TARRYTOWN, N.Y., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will…

dpa-AFX ProFeed